Chengdu Kanghong Biotech Co.,Ltd.
http://www.cn-kanghong.com/English/about_f.jsp
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Chengdu Kanghong Biotech Co.,Ltd.
Stock Watch: All Bayer’s Roads Lead To Unpalatable
Investors reacted quite differently to Bayer’s first-quarter results and those of its licensing partner Regeneron. There are sound reasons for this. It seems unlikely that one will help the other.
Stock Watch: All Bayer’s Roads Lead To Unpalatable
Investors reacted quite differently to Bayer’s first-quarter results and those of its licensing partner Regeneron. There are sound reasons for this. It seems unlikely that one will help the other.
Chinese Firms At JPM Not About China, It’s Time To Go Global
From BeiGene to Innovent to Wuxi Biologics, executives at Chinese pharma firms are now discussing collaborations to go beyond China to become biopharma operations with a truly global presence.
Regulators Moving Ahead Of Industry In China? Officials, Execs Weigh In
While regulators are steaming ahead to accelerate clinical trial and product approvals, China's pharma industry still lacks innovation. Underlying the hot investment, multi-million deals and IPOs is a lingering reliance on 'fast-following,' regulators and pharma execs tell the DIA China meeting.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Sichuan Jishengtang Pharmaceuticals Co., Ltd.
- Chengdu Hongda Pharmaceuticals Co., Ltd.
- IOPtima Ltd
- Kanghong & Sagent (Chengdu) Pharmaceuticals Co., Ltd.
- Chengdu Kanghong biological Science & Technology Co., Ltd.
- Kanghong Biotechnology Co., Ltd.
- Shanghai Kanghong Weichi Biotechnology Co., Ltd.
- Sichuan Kanghong Medicine Trade Co., Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice